Guest Contributors

Will Lee Will Lee, VP of Science at Helix	Brendan Lee Brendan Lee, President of ASHG	Leigh, Peter CEO, Microsonic Systems
Dave Lennon David Lennon, CEO of Satellite Bio	Sabina Leonelli Philosopher, University of Exeter	Emily Leproust Emily Leproust, CEO and Co-Founder, Twist Bioscience
Olivier Lesueur Olivier Lesueur, Partner at Bionest	Tony Letai Tony Letai, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute	Levine, Daniel Managing Director, Burrill & Company
Danny Levner Daniel Levner Co-Founder and Chairman of the Scientific Advisory Board, Sight Dx	Ivan Liachko Ivan Liachko, CEO & CSO of Phase Genomics	Jimmy Lin Founder, Rare Genomics Institute
Lin, Dawei, PhD Director of the Bioinformatics Core at UC Davis Genome Center	Shirley Liu Shirley Liu, Professor of Biostatisitcs at Harvard, Co-Director of the Center for Fuctional Cancer Epigenetics at the Dana Farber Cancer Institute	Terry Lo Terry Lo, CEO at Vizgen
Matt Loose Matt Loose, Professor of Developmental and Computational Biology, Faculty of Medicine & Health Sciences, University of Nottingham	Lu, Yi, PhD Professor, University of Illinois	Lustig, Kevin, PhD CEO, Assay Depot
Elaine Lyon Clinical Services Lab Director at HudsonAlpha Institute for Biotechnology	Gholson Lyon @GholsonLyon	Sandy Macrae Sandy Macrae, CEO of Sangamo
Maderis, Gail President and CEO, BayBio	Jerome Madison Jerome Madison, General Manager of Oncology for Invitae	Malow, Brian Science Comedian
Elizabeth Mansfield Deputy Office Director of Personalized Medicine, OIR, FDA